In-vitro 3D modelling for charged particle therapy – Uncertainties and opportunities
- 1 December 2021
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 179, 114018
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Radiation as an Immune ModulatorSeminars in Radiation Oncology, 2013
- Linear Energy Transfer-Guided Optimization in Intensity Modulated Proton Therapy: Feasibility Study and Clinical PotentialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Induction and Repair of Clustered DNA Lesions: What Do We Know So Far?Radiation Research, 2013
- 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testingBMC Cancer, 2013
- Tumor Spheroids as an In Vitro Model for Determining the Therapeutic Response to Proton Beam Radiotherapy and Thermally Sensitive NanocarriersTheranostics, 2013
- Revisiting the ultra-high dose rate effect: implications for charged particle radiotherapy using protons and light ionsBritish Journal of Radiology, 2012
- DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cellsCell Cycle, 2008
- Modeling Tissue Morphogenesis and Cancer in 3DCell, 2007
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyJournal of Experimental Medicine, 2006
- Quantitation of Cellular Radiobiological ResponsesAnnual Review of Nuclear Science, 1964